Authors: BERNOTATDANIELOWSKI S MELZER G ROHMANN S HAUNSCHILD J GANTE J JURASZYK H WURZIGER H

Citation: S. Bernotatdanielowski et al., IN-VITRO AND IN-VIVO PHARMACOLOGY OF THE NOVEL, ORALLY-ACTIVE GPIIBIIIA-ANTAGONIST EMD-122-347 AND ITS ACTIVE-DRUG EMD-132-338, Thrombosis and haemostasis, 1997, pp. 1601-1601

Authors: GANTE J JURASZYK H RADDATZ P WURZIGER H BERNOTATDANIELOWSKI S MELZER G RIPPMANN F

Citation: J. Gante et al., NEW ANTITHROMBOTIC RGD-MIMETICS WITH HIGH BIOAVAILABILITY, Bioorganic & medicinal chemistry letters, 6(20), 1996, pp. 2425-2430

Authors: JONAS R KLOCKOW M LUES I WURZIGER H

Citation: R. Jonas et al., STEREOSELECTIVITY OF THE POSITIVE INOTROPIC EFFECTS OF NEWER DIAZINONE-CARDIOTONICS, Bioorganic & medicinal chemistry letters, 4(21), 1994, pp. 2585-2588

Authors: JONAS R KLOCKOW M LUES I PRUCHER H SCHLIEP HJ WURZIGER H

Citation: R. Jonas et al., SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF MERIBENDAN AND RELATED HETEROCYCLIC BENZIMIDAZOLO-PYRIDAZINONES, European journal of medicinal chemistry, 28(2), 1993, pp. 129-140

Authors: JONAS R PRUCHER H WURZIGER H

Citation: R. Jonas et al., SYNTHESIS OF A NEW TYPE OF BENT HETEROCYCLIC BENZIMIDAZOLO-PYRIDAZINONES, European journal of medicinal chemistry, 28(2), 1993, pp. 141-148